» Articles » PMID: 30328013

CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus

Overview
Journal Virol Sin
Specialty Microbiology
Date 2018 Oct 18
PMID 30328013
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclophilin A (CypA) is a peptidyl-prolyl cis/trans isomerase that interacts with the matrix protein (M1) of influenza A virus (IAV) and restricts virus replication by regulating the ubiquitin-proteasome-mediated degradation of M1. However, the mechanism by which CypA regulates M1 ubiquitination remains unknown. In this study, we reported that E3 ubiquitin ligase AIP4 promoted K48-linked ubiquitination of M1 at K102 and K104, and accelerated ubiquitin-proteasome-mediated degradation of M1. The recombinant IAV with mutant M1 (K102R/K104R) could not be rescued, suggesting that the ubiquitination of M1 at K102/K104 was essential for IAV replication. Furthermore, CypA inhibited AIP4-mediated M1 ubiquitination by impairing the interaction between AIP4 and M1. More importantly, both the mutations of M1 (K102R/K104R) and CypA inhibited the nuclear export of M1, indicating that CypA regulates the cellular localization of M1 via inhibition of AIP4-mediated M1 ubiquitination at K102 and K104, which results in the reduced replication of IAV. Collectively, our findings reveal a novel ubiquitination-based mechanism by which CypA regulates the replication of IAV.

Citing Articles

Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.

Husain M Pathogens. 2024; 13(2).

PMID: 38392865 PMC: 10893265. DOI: 10.3390/pathogens13020127.


Cyclophilin A facilitates influenza B virus replication by stabilizing viral proteins.

Li H, Fan W, Min J, Bai X, Yang W, Li H iScience. 2023; 26(12):108515.

PMID: 38089580 PMC: 10711473. DOI: 10.1016/j.isci.2023.108515.


PROTAC targeting cyclophilin A controls virus-induced cytokine storm.

Li H, Yang W, Li H, Bai X, Zhang H, Fan W iScience. 2023; 26(9):107535.

PMID: 37636080 PMC: 10448112. DOI: 10.1016/j.isci.2023.107535.


Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs.

Guan L, Ping J, Lopes T, Fan S, Presler R, Neumann G Vaccines (Basel). 2023; 11(8).

PMID: 37631932 PMC: 10459923. DOI: 10.3390/vaccines11081364.


NbMLP43 Ubiquitination and Proteasomal Degradation via the Light Responsive Factor NbBBX24 to Promote Viral Infection.

Song L, Jiao Y, Song H, Shao Y, Zhang D, Ding C Cells. 2023; 12(4).

PMID: 36831257 PMC: 9954743. DOI: 10.3390/cells12040590.


References
1.
Bui M, Wills E, Helenius A, Whittaker G . Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol. 2000; 74(4):1781-6. PMC: 111655. DOI: 10.1128/jvi.74.4.1781-1786.2000. View

2.
Baudin F, Petit I, Weissenhorn W, Ruigrok R . In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology. 2001; 281(1):102-8. DOI: 10.1006/viro.2000.0804. View

3.
Khor R, McElroy L, Whittaker G . The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic. 2003; 4(12):857-68. DOI: 10.1046/j.1398-9219.2003.0140.x. View

4.
Burleigh L, Calder L, Skehel J, Steinhauer D . Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol. 2004; 79(2):1262-70. PMC: 538569. DOI: 10.1128/JVI.79.2.1262-1270.2005. View

5.
Luban J . Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol. 2006; 81(3):1054-61. PMC: 1797489. DOI: 10.1128/JVI.01519-06. View